Department of Anesthesiology, Shengjing Hospital, China Medical University, Shenyang 110004, People's Republic of China.
Drug Des Devel Ther. 2020 Nov 2;14:4703-4715. doi: 10.2147/DDDT.S266726. eCollection 2020.
The physiologic transition from a fetus to a neonate is composed of a series of complex processes that include changes in cerebral tissue oxygenation saturation (cSO). Monitoring this process is of great importance. This study aimed to define the cSO reference interval in neonates without medical support, extending the measurements until 1 hour after birth, and to determine the incidence of abnormally low or high regional cerebral oxygenation during the neonatal transition.
A total of 418 neonates delivered by cesarean section were enrolled. Near-infrared spectroscopy was used to monitor cerebral oxygenation.
We found that cSO of the non-oxygen-inhaled intrathecal anesthesia in neonates without medical support increased from about 49.0% in the second minute. Most of them reached cSO relative stabilization at 55.7-81.0% between 7 and 8 minutes after birth. One hour after birth, newborn cSO was maintained at 78.0-87.0%. The low cSO rate among babies born under intrathecal anesthesia with and without maternal oxygen inhalation during cesarean sections was approximately 4.5% and 9.0%, respectively.
We reported the trend in cSO from 2 minutes after birth to 1 hour in the neonatal nursing room and determined the incidence of abnormal regional cSO during this neonatal transition period. Anesthesiologists should pay special attention to the risk of cSO abnormalities in newborns when managing pregnant women with comorbidities.
胎儿到新生儿的生理转变由一系列复杂过程组成,包括脑组织氧饱和度(cSO)的变化。监测这一过程非常重要。本研究旨在定义无医疗支持的新生儿的 cSO 参考区间,将测量时间延长至出生后 1 小时,并确定新生儿过渡期区域性脑氧合异常低或高的发生率。
共纳入 418 例剖宫产分娩的新生儿。采用近红外光谱技术监测脑氧合。
我们发现,无医疗支持的椎管内麻醉新生儿 cSO 在第 2 分钟时约为 49.0%,随后增加。大多数新生儿在出生后 7-8 分钟内 cSO 相对稳定在 55.7-81.0%。出生后 1 小时,新生儿 cSO 维持在 78.0-87.0%。椎管内麻醉新生儿 cSO 低值率约为 4.5%,产妇吸氧与不吸氧的剖宫产新生儿 cSO 低值率约为 9.0%。
我们报告了新生儿护理室出生后 2 分钟至 1 小时 cSO 的趋势,并确定了这一新生儿过渡期区域性 cSO 异常的发生率。麻醉师在管理患有合并症的孕妇时,应特别注意 cSO 异常的风险。